-
1
-
-
20844443468
-
WHO-EORTC classification for cutaneous lymphomas
-
PMID:15692063
-
Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768-85; PMID:15692063; http://dx.doi.org/10.1182/blood- 2004-09-3502
-
(2005)
Blood
, vol.105
, pp. 3768-3785
-
-
Willemze, R.1
Jaffe, E.S.2
Burg, G.3
Cerroni, L.4
Berti, E.5
Swerdlow, S.H.6
Ralfkiaer, E.7
Chimenti, S.8
Diaz-Perez, J.L.9
Duncan, L.M.10
-
2
-
-
84908179264
-
Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patientderived cell lines
-
PMID:24231773
-
Ivan V, Litvinov BC, Simon Fredholm, Niels Ødum, Hanieh Zargham, Yuanshen Huang, Youwen Zhou, Kevin Pehr, Kupper Thomas S, Anders Woetmann, Denis Sasseville. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patientderived cell lines. Cell Cycle 2014; 13:1-8; PMID:24231773; http://dx.doi.org/10.4161/cc.27017
-
(2014)
Cell Cycle
, vol.13
, pp. 1-8
-
-
Ivan, V.1
Litvinov, B.C.2
Fredholm, S.3
Ødum, N.4
Zargham, H.5
Huang, Y.6
Zhou, Y.7
Pehr, K.8
Kupper Thomas, S.9
Woetmann, A.10
Sasseville, D.11
-
3
-
-
0042744782
-
Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: An expression profile study
-
PMID:12689942
-
Tracey L, Villuendas R, Dotor AM, Spiteri I, Ortiz P, Garcia JF, Peralto JL, Lawler M, Piris MA. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood 2003; 102:1042-50; PMID:12689942; http://dx.doi.org/10.1182/blood- 2002-11-3574
-
(2003)
Blood
, vol.102
, pp. 1042-1050
-
-
Tracey, L.1
Villuendas, R.2
Dotor, A.M.3
Spiteri, I.4
Ortiz, P.5
Garcia, J.F.6
Peralto, J.L.7
Lawler, M.8
Piris, M.A.9
-
4
-
-
0033215166
-
Depressed IL-12-mediated signal transduction in T cells from patients with Sezary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4
-
Showe LC, Fox FE, Williams D, Au K, Niu Z, Rook AH. Depressed IL-12-mediated signal transduction in T cells from patients with Sezary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. J Immunol 1999; 163:4073-9.
-
(1999)
J Immunol
, vol.163
, pp. 4073-4079
-
-
Showe, L.C.1
Fox, F.E.2
Williams, D.3
Au, K.4
Niu, Z.5
Rook, A.H.6
-
6
-
-
12444335268
-
Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma
-
PMID:12782714
-
Kari L, Loboda A, Nebozhyn M, Rook AH, Vonderheid EC, Nichols C, Virok D, Chang C, Horng WH, Johnston J, et al. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 2003; 197:1477-88; PMID:12782714; http://dx.doi.org/10.1084/jem.20021726
-
(2003)
J Exp Med
, vol.197
, pp. 1477-1488
-
-
Kari, L.1
Loboda, A.2
Nebozhyn, M.3
Rook, A.H.4
Vonderheid, E.C.5
Nichols, C.6
Virok, D.7
Chang, C.8
Horng, W.H.9
Johnston, J.10
-
7
-
-
33645734738
-
Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy
-
PMID:16403914
-
Nebozhyn M, Loboda A, Kari L, Rook AH, Vonderheid EC, Lessin S, et al. Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy. Blood 2006; 107:3189-96; PMID:16403914; http://dx.doi.org/10.1182/blood-2005-07-2813
-
(2006)
Blood
, vol.107
, pp. 3189-3196
-
-
Nebozhyn, M.1
Loboda, A.2
Kari, L.3
Rook, A.H.4
Vonderheid, E.C.5
Lessin, S.6
-
8
-
-
4143079424
-
Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis
-
PMID:15313894
-
van Doorn R, Dijkman R, Vermeer MH, Out-Luiting JJ, van der Raaij-Helmer EM, Willemze R, Tensen CP. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis. Cancer Res 2004; 64:5578-86; PMID:15313894; http://dx. doi.org/10.1158/0008-5472.CAN-04-1253
-
(2004)
Cancer Res
, vol.64
, pp. 5578-5586
-
-
Van Doorn, R.1
Dijkman, R.2
Vermeer, M.H.3
Out-Luiting, J.J.4
Van Der-Raaij-Helmer, E.M.5
Willemze, R.6
Tensen, C.P.7
-
9
-
-
17344388275
-
The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma
-
PMID:8958942
-
Rook AH, Kubin M, Fox FE, Niu Z, Cassin M, Vowels BR, Gottleib SL, Vonderheid EC, Lessin SR, Trinchieri G. The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma. Ann N Y Acad Sci 1996; 795:310-8; PMID:8958942; http://dx.doi.org/10.1111/j.1749-6632.1996.tb52680.x
-
(1996)
Ann N y Acad Sci
, vol.795
, pp. 310-318
-
-
Rook, A.H.1
Kubin, M.2
Fox, F.E.3
Niu, Z.4
Cassin, M.5
Vowels, B.R.6
Gottleib, S.L.7
Vonderheid, E.C.8
Lessin, S.R.9
Trinchieri, G.10
-
10
-
-
0033178680
-
Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses
-
PMID:10419880
-
Rook AH, Wood GS, Yoo EK, Elenitsas R, Kao DM, Sherman ML, Witmer WK, Rockwell KA, Shane RB, Lessin SR, et al. Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses. Blood 1999; 94:902-8; PMID:10419880
-
(1999)
Blood
, vol.94
, pp. 902-908
-
-
Rook, A.H.1
Wood, G.S.2
Yoo, E.K.3
Elenitsas, R.4
Kao, D.M.5
Sherman, M.L.6
Witmer, W.K.7
Rockwell, K.A.8
Shane, R.B.9
Lessin, S.R.10
-
11
-
-
84879398642
-
STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma
-
PMID:23676217
-
Kopp KL, Ralfkiaer U, Gjerdrum LM, Helvad R, Pedersen IH, Litman T, Jønson L, Hagedorn PH, Krejsgaard T, Gniadecki R, et al. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle 2013; 12:1939-47; PMID:23676217; http://dx.doi.org/10.4161/cc.24987
-
(2013)
Cell Cycle
, vol.12
, pp. 1939-1947
-
-
Kopp, K.L.1
Ralfkiaer, U.2
Gjerdrum, L.M.3
Helvad, R.4
Pedersen, I.H.5
Litman, T.6
Jønson, L.7
Hagedorn, P.H.8
Krejsgaard, T.9
Gniadecki, R.10
-
12
-
-
34447129566
-
Transcription factor profiling shows new ways towards new treatment options of cutaneous T cell lymphomas
-
PMID:17630925
-
Dobbeling U. Transcription factor profiling shows new ways towards new treatment options of cutaneous T cell lymphomas. Curr Drug Discov Technol 2007; 4:24-30; PMID:17630925; http://dx.doi.org/10.2174/157016307781115467
-
(2007)
Curr Drug Discov Technol
, vol.4
, pp. 24-30
-
-
Dobbeling, U.1
-
13
-
-
0034792532
-
Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells
-
PMID:11564163
-
Qin JZ, Kamarashev J, Zhang CL, Dummer R, Burg G, Dobbeling U. Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol 2001; 117:583-9; PMID:11564163; http://dx.doi.org/10.1046/j.0022-202x.2001.01436.x
-
(2001)
J Invest Dermatol
, vol.117
, pp. 583-589
-
-
Qin, J.Z.1
Kamarashev, J.2
Zhang, C.L.3
Dummer, R.4
Burg, G.5
Dobbeling, U.6
-
14
-
-
0035525783
-
Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells
-
PMID:11675351
-
Qin JZ, Zhang CL, Kamarashev J, Dummer R, Burg G, Dobbeling U. Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood 2001; 98:2778-83; PMID:11675351; http://dx.doi.org/10.1182/blood. V98.9.2778
-
(2001)
Blood
, vol.98
, pp. 2778-2783
-
-
Qin, J.Z.1
Zhang, C.L.2
Kamarashev, J.3
Dummer, R.4
Burg, G.5
Dobbeling, U.6
-
15
-
-
84880541882
-
Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155
-
PMID:23803726
-
Litvinov IV, Pehr K, Sasseville D. Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155. Cell Cycle 2013; 12:2172-3; PMID:23803726; http://dx. doi.org/10.4161/cc.25550
-
(2013)
Cell Cycle
, vol.12
, pp. 2172-2173
-
-
Litvinov, I.V.1
Pehr, K.2
Sasseville, D.3
-
16
-
-
79953197948
-
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer
-
PMID:21383199
-
Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, Croce CM. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. ProcNat Acad Sci U S A 2011; 108: 4908-13; PMID:21383199; http://dx.doi.org/10.1073/pnas.1101795108
-
(2011)
ProcNat Acad Sci U S A
, vol.108
, pp. 4908-4913
-
-
Tili, E.1
Michaille, J.J.2
Wernicke, D.3
Alder, H.4
Costinean, S.5
Volinia, S.6
Croce, C.M.7
-
17
-
-
14844354250
-
Accumulation of miR-155 and BIC RNA in human B cell lymphomas
-
PMID:15738415
-
Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Nat Acad Sci U S A 2005; 102:3627-32; PMID:15738415; http://dx.doi.org/10.1073/pnas.0500613102
-
(2005)
Proc Nat Acad Sci U S A
, vol.102
, pp. 3627-3632
-
-
Eis, P.S.1
Tam, W.2
Sun, L.3
Chadburn, A.4
Li, Z.5
Gomez, M.F.6
Lund, E.7
Dahlberg, J.E.8
-
18
-
-
80155124637
-
Diagnostic micro-RNA profiling in cutaneous T-cell lymphoma (CTCL)
-
PMID:21865341
-
Ralfkiaer U, Hagedorn PH, Bangsgaard N, Lovendorf MB, Ahler CB, Svensson L, Kopp KL, Vennegaard MT, Lauenborg B, Zibert JR, et al. Diagnostic micro-RNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 2011; 118:5891-900; PMID:21865341; http://dx.doi.org/10.1182/blood-2011-06-358382
-
(2011)
Blood
, vol.118
, pp. 5891-5900
-
-
Ralfkiaer, U.1
Hagedorn, P.H.2
Bangsgaard, N.3
Lovendorf, M.B.4
Ahler, C.B.5
Svensson, L.6
Kopp, K.L.7
Vennegaard, M.T.8
Lauenborg, B.9
Zibert, J.R.10
-
19
-
-
84886290618
-
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
-
PMID:23998443
-
Wong HK. Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma. Discov Med 2013; 16:71-8; PMID:23998443
-
(2013)
Discov Med
, vol.16
, pp. 71-78
-
-
Wong, H.K.1
-
20
-
-
33644814867
-
Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: Relevance to mechanism of therapeutic action
-
PMID:16297208
-
Zhang C, Richon V, Ni X, Talpur R, Duvic M. Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. J Invest Dermatol 2005; 125:1045-52; PMID:16297208; http://dx.doi.org/10.1111/j.0022-202X.2005.23925.x
-
(2005)
J Invest Dermatol
, vol.125
, pp. 1045-1052
-
-
Zhang, C.1
Richon, V.2
Ni, X.3
Talpur, R.4
Duvic, M.5
-
21
-
-
77954475631
-
The role of histone deacetylase inhibitors in the treatment of patients with cutaneous T-cell lymphoma
-
Hymes KB. The role of histone deacetylase inhibitors in the treatment of patients with cutaneous T-cell lymphoma. Clin Lymphoma, Myeloma & Leukemia 2010; 10:98-109; http://dx.doi.org/10.3816/CLML.2010. n.014
-
(2010)
Clin Lymphoma, Myeloma & Leukemia
, vol.10
, pp. 98-109
-
-
Hymes, K.B.1
-
22
-
-
0242285719
-
STAT proteins: From normal control of cellular events to tumorigenesis
-
PMID:14502555
-
Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003; 197:157-68; PMID:14502555; http://dx.doi.org/10.1002/jcp.10364
-
(2003)
J Cell Physiol
, vol.197
, pp. 157-168
-
-
Calo, V.1
Migliavacca, M.2
Bazan, V.3
MacAluso, M.4
Buscemi, M.5
Gebbia, N.6
Russo, A.7
-
23
-
-
84855949597
-
Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sezary syndrome
-
PMID:21938013
-
van der Fits L, Out-Luiting JJ, van Leeuwen MA, Samsom JN, Willemze R, Tensen CP, Vermeer MH. Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sezary syndrome. J Invest Dermatol 2012; 132:440-7; PMID:21938013; http://dx.doi.org/10.1038/jid.2011.293
-
(2012)
J Invest Dermatol
, vol.132
, pp. 440-447
-
-
Van Der-Fits, L.1
Out-Luiting, J.J.2
Van Leeuwen, M.A.3
Samsom, J.N.4
Willemze, R.5
Tensen, C.P.6
Vermeer, M.H.7
-
24
-
-
0033052910
-
Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells
-
PMID:10374878
-
Nielsen M, Kaestel CG, Eriksen KW, Woetmann A, Stokkedal T, Kaltoft K, Geisler C, Röpke C, Odum N. Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 1999; 13:735-8; PMID:10374878; http://dx.doi.org/10.1038/sj.leu.2401415
-
(1999)
Leukemia
, vol.13
, pp. 735-738
-
-
Nielsen, M.1
Kaestel, C.G.2
Eriksen, K.W.3
Woetmann, A.4
Stokkedal, T.5
Kaltoft, K.6
Geisler, C.7
Röpke, C.8
Odum, N.9
-
25
-
-
44949105638
-
Cucurbitacin I inhibits Stat3 and induces apoptosis in Sezary cells
-
PMID:18200050
-
van Kester MS, Out-Luiting JJ, von dem Borne PA, Willemze R, Tensen CP, Vermeer MH. Cucurbitacin I inhibits Stat3 and induces apoptosis in Sezary cells. J Invest Dermatol 2008; 128:1691-5; PMID:18200050; http://dx.doi.org/10.1038/sj.jid.5701246
-
(2008)
J Invest Dermatol
, vol.128
, pp. 1691-1695
-
-
Van Kester, M.S.1
Out-Luiting, J.J.2
Von Dem-Borne, P.A.3
Willemze, R.4
Tensen, C.P.5
Vermeer, M.H.6
-
26
-
-
0035017383
-
Constitutive STAT3-activation in Sezary syndrome: Tyrphostin AG490 inhibits STAT3- activation, interleukin-2 receptor expression and growth of leukemic Sezary cells
-
PMID:11368440
-
Eriksen KW, Kaltoft K, Mikkelsen G, Nielsen M, Zhang Q, Geisler C, Nissen MH, Röpke C, Wasik MA, Odum N. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3- activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Leukemia 2001; 15:787-93; PMID:11368440; http://dx.doi.org/10.1038/sj.leu.2402093
-
(2001)
Leukemia
, vol.15
, pp. 787-793
-
-
Eriksen, K.W.1
Kaltoft, K.2
Mikkelsen, G.3
Nielsen, M.4
Zhang, Q.5
Geisler, C.6
Nissen, M.H.7
Röpke, C.8
Wasik, M.A.9
Odum, N.10
-
27
-
-
79951516643
-
MicroRNA-21 expression in CD4C T cells is regulated by STAT3 and is pathologically involved in Sezary syndrome
-
PMID:21085192
-
van der Fits L, van Kester MS, Qin Y, Out-Luiting JJ, Smit F, Zoutman WH, Willemze R, Tensen CP, Vermeer MH. MicroRNA-21 expression in CD4C T cells is regulated by STAT3 and is pathologically involved in Sezary syndrome. J Invest Dermatol 2011; 131:762-8; PMID:21085192; http://dx.doi.org/10.1038/jid.2010.349
-
(2011)
J Invest Dermatol
, vol.131
, pp. 762-768
-
-
Van Der-Fits, L.1
Van Kester, M.S.2
Qin, Y.3
Out-Luiting, J.J.4
Smit, F.5
Zoutman, W.H.6
Willemze, R.7
Tensen, C.P.8
Vermeer, M.H.9
-
28
-
-
33750067975
-
Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma
-
PMID:16932349
-
Krejsgaard T, Vetter-Kauczok CS, Woetmann A, Lovato P, Labuda T, Eriksen KW, Zhang Q, Becker JC, Ødum N. Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma. Leukemia 2006; 20:1759-66; PMID: 16932349; http://dx.doi.org/10.1038/sj.leu.2404350
-
(2006)
Leukemia
, vol.20
, pp. 1759-1766
-
-
Krejsgaard, T.1
Vetter-Kauczok, C.S.2
Woetmann, A.3
Lovato, P.4
Labuda, T.5
Eriksen, K.W.6
Zhang, Q.7
Becker, J.C.8
Ødum, N.9
-
29
-
-
84055184933
-
The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma
-
PMID:22236880
-
Abraham RM, Zhang Q, Odum N, Wasik MA. The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma. Cancer Biol Ther 2011; 12:1019-22; PMID:22236880; http://dx.doi.org/10.4161/cbt.12.12.18144
-
(2011)
Cancer Biol Ther
, vol.12
, pp. 1019-1022
-
-
Abraham, R.M.1
Zhang, Q.2
Odum, N.3
Wasik, M.A.4
-
30
-
-
13544261739
-
Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha
-
PMID:15618960
-
Brender C, Lovato P, Sommer VH, Woetmann A, Mathiesen AM, Geisler C, Wasik M, Ødum N. Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. Leukemia 2005; 19:209-13; PMID:15618960; http://dx.doi.org/10.1038/sj.leu.2403610
-
(2005)
Leukemia
, vol.19
, pp. 209-213
-
-
Brender, C.1
Lovato, P.2
Sommer, V.H.3
Woetmann, A.4
Mathiesen, A.M.5
Geisler, C.6
Wasik, M.7
Ødum, N.8
-
31
-
-
0346367061
-
Interleukin-2 receptordirected therapies for cutaneous lymphomas
-
PMID:14710895
-
Foss FM, Waldmann TA. Interleukin-2 receptordirected therapies for cutaneous lymphomas. Hematol/Oncol Clin North Am 2003; 17:1449-58; PMID:14710895; http://dx.doi.org/10.1016/S0889-8588(03)00110-2
-
(2003)
Hematol/Oncol Clin North Am
, vol.17
, pp. 1449-1458
-
-
Foss, F.M.1
Waldmann, T.A.2
-
32
-
-
35948966315
-
STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression
-
PMID:17922009
-
Zhang Q, Wang HY, Liu X, Wasik MA. STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression. Nat Med 2007; 13:1341-8; PMID:17922009; http://dx.doi.org/10.1038/nm1659
-
(2007)
Nat Med
, vol.13
, pp. 1341-1348
-
-
Zhang, Q.1
Wang, H.Y.2
Liu, X.3
Wasik, M.A.4
-
33
-
-
0033520313
-
Cellular physiology of STAT3: Where's the cytoplasmic monomer?
-
PMID:10464281
-
Ndubuisi MI, Guo GG, Fried VA, Etlinger JD, Sehgal PB. Cellular physiology of STAT3: Where's the cytoplasmic monomer? J Biol Chem 1999; 274:25499-509; PMID:10464281; http://dx.doi.org/10.1074/jbc.274.36. 25499
-
(1999)
J Biol Chem
, vol.274
, pp. 25499-25509
-
-
Ndubuisi, M.I.1
Guo, G.G.2
Fried, V.A.3
Etlinger, J.D.4
Sehgal, P.B.5
-
34
-
-
2442459084
-
Plasma membrane rafts and chaperones in cytokine/STAT signaling
-
PMID:14515141
-
Sehgal PB. Plasma membrane rafts and chaperones in cytokine/STAT signaling. Acta Biochim Pol 2003; 50:583-94; PMID:14515141
-
(2003)
Acta Biochim Pol
, vol.50
, pp. 583-594
-
-
Sehgal, P.B.1
-
35
-
-
0036840235
-
Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma
-
PMID:12414529
-
Tracey L, Villuendas R, Ortiz P, Dopazo A, Spiteri I, Lombardia L, Rodríguez-Peralto JL, Fernández-Herrera J, Hernández A, Fraga J, et al. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol 2002; 161:1825-37; PMID:12414529; http://dx.doi.org/10.1016/S0002-9440(10)64459-8
-
(2002)
Am J Pathol
, vol.161
, pp. 1825-1837
-
-
Tracey, L.1
Villuendas, R.2
Ortiz, P.3
Dopazo, A.4
Spiteri, I.5
Lombardia, L.6
Rodríguez-Peralto, J.L.7
Fernández-Herrera, J.8
Hernández, A.9
Fraga, J.10
-
36
-
-
84889058668
-
STAT inhibitors for cancer therapy
-
PMID:24308725
-
Furqan M, Akinleye A, Mukhi N, Mittal V, Chen Y, Liu D. STAT inhibitors for cancer therapy. J Hematol Oncol 2013; 6:90; PMID:24308725; http://dx.doi.org/10.1186/1756-8722-6-90
-
(2013)
J Hematol Oncol
, vol.6
, pp. 90
-
-
Furqan, M.1
Akinleye, A.2
Mukhi, N.3
Mittal, V.4
Chen, Y.5
Liu, D.6
-
37
-
-
84904733767
-
Systematic review of tofacitinib: A new drug for the management of rheumatoid arthritis
-
PMID:25047498
-
Kaur K, Kalra S, Kaushal S. Systematic Review of Tofacitinib: A New Drug for the Management of Rheumatoid Arthritis. Clin Ther 2014; 36:1074-86; PMID:25047498; http://dx.doi.org/10.1016/j. clinthera.2014.06.018
-
(2014)
Clin Ther
, vol.36
, pp. 1074-1086
-
-
Kaur, K.1
Kalra, S.2
Kaushal, S.3
|